FY19 Labor-HHS Appropriations - House Subcommittee Draft/S.3158
FDA drug development and clinical trials; Precision Medicine Initiative; Patient Access to Care; Drug Pricing
CMS coverage policies - re: oxygen, Medicare reimbursement
Duration: July 15, 2015
to
August 31, 2018
General Issues: Budget/Appropriations , Health Issues , Medicare/Medicaid
Spending: about $310,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2015: U.S. Senate, House of Representatives, Natl Institutes of Health (NIH), Food & Drug Administration (FDA)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
3rd Quarter, 2018
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. terminated an engagement in which they represented Alpha-1 Foundation on Oct. 18, 2018.
Original Filing: 300988540.xml
Lobbying Issues
FY19 Labor-HHS Appropriations - House Subcommittee Draft/S.3158
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
FDA drug development and clinical trials; Precision Medicine Initiative; Patient Access to Care; Drug Pricing
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
CMS coverage policies - re: oxygen, Medicare reimbursement
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
2nd Quarter, 2018
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Alpha-1 Foundation , earning $30,000. The report was filed on July 17, 2018.
Original Filing: 300966493.xml
Lobbying Issues
FY19 Labor-HHS Appropriations - House Subcommittee Draft/S.3158
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
FDA drug development and clinical trials; Precision Medicine Initiative; Patient Access to Care; Drug Pricing
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
CMS coverage policies - re: oxygen, Medicare reimbursement
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
1st Quarter, 2018
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Alpha-1 Foundation , earning $30,000. The report was filed on April 17, 2018.
Original Filing: 300945676.xml
Lobbying Issues
H.R.3358/S.1771 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018
HR 1625, Consolidated Appropriations Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
FDA drug development and clinical trials; Precision Medicine Initiative; Patient Access to Care
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
CMS coverage policies - re: oxygen, Medicare reimbursement
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
4th Quarter, 2017
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Alpha-1 Foundation , earning $30,000. The report was filed on Jan. 22, 2018.
Original Filing: 300933725.xml
Lobbying Issues
H.R.3358/S.1771 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
FDA drug development and clinical trials; Precision Medicine Initiative; American Health Care Act HR 1628, Patient Access to Care
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
CMS coverage policies - re: oxygen, Medicare reimbursement
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
3rd Quarter, 2017
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Alpha-1 Foundation , earning $30,000. The report was filed on Oct. 18, 2017.
Original Filing: 300907331.xml
Lobbying Issues
H.R.3358/S.1771 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
FDA drug development and clinical trials; Precision Medicine Initiative; American Health Care Act HR 1628, Better Care Reconciliation Act HR 1628, Graham Cassidy
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
CMS coverage policies - re: oxygen, Medicare reimbursement
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
2nd Quarter, 2017
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Alpha-1 Foundation , earning $20,000. The report was filed on July 17, 2017.
Original Filing: 300885755.xml
Lobbying Issues
FY 17 Labor-HHS-Appropriations/FY 18 Labor-HHS-Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
FDA drug development and clinical trials; Precision Medicine Initiative; American Health Care Act HR 1628, Better Care Reconciliation Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
CMS coverage policies - re: oxygen, Medicare reimbursement
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
1st Quarter, 2017
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Alpha-1 Foundation , earning $20,000. The report was filed on April 18, 2017.
Original Filing: 300867728.xml
Lobbying Issues
FY 17 Labor-HHS-Appropriations/FY 18 Labor-HHS-Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
FDA drug development and clinical trials; 21st Century Cures/Innovations for Healthier Americans; Precision Medicine Initiative; Public Law No. 114-255
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
CMS coverage policies - re: oxygen, Medicare reimbursement
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
4th Quarter, 2016
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Alpha-1 Foundation , earning $20,000. The report was filed on Jan. 10, 2017.
Original Filing: 300844550.xml
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
FDA drug development and clinical trials; 21st Century Cures/Innovations for Healthier Americans; Precision Medicine Initiative
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
CMS coverage policies - re: oxygen; Medicare reimbursement
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
3rd Quarter, 2016
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Alpha-1 Foundation , earning $20,000. The report was filed on Oct. 17, 2016.
Original Filing: 300829076.xml
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
FDA drug development and clinical trials; 21st Century Cures/Innovations for Healthier Americans; Precision Medicine Initiative
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
CMS coverage policies - re: oxygen; Medicare reimbursement
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
2nd Quarter, 2016
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Alpha-1 Foundation , earning $20,000. The report was filed on July 15, 2016.
Original Filing: 300810510.xml
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
FDA drug development and clinical trials; 21st Century Cures/Innovations for Healthier Americans; Precision Medicine Initiative
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
CMS coverage policies - re: oxygen; Medicare reimbursement
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
1st Quarter, 2016
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Alpha-1 Foundation , earning $20,000. The report was filed on April 12, 2016.
Original Filing: 300790083.xml
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
FDA drug development and clinical trials; 21st Century Cures/Innovations for Healthier Americans
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
CMS coverage policies - re: oxygen; Medicare reimbursement
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
4th Quarter, 2015
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Alpha-1 Foundation , earning $20,000. The report was filed on Jan. 13, 2016.
Original Filing: 300771086.xml
Lobbying Issues
FY 16 Labor HHS; HR 2029 Consolidated Appropriations Act, 2016
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
FDA drug development and clinical trials; 21st Century Cures
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
CMS coverage policies - re: oxygen; Medicare reimbursement
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
3rd Quarter, 2015
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Alpha-1 Foundation , earning $20,000. The report was filed on Oct. 13, 2015.
Original Filing: 300752273.xml
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
FDA drug development and clinical trials; 21st Century Cures
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
Lobbying Issues
CMS coverage policies - re: oxygen; Medicare reimbursement
Agencies Lobbied
U.S. Senate U.S. House of Representatives Natl Institutes of Health (NIH) Food & Drug Administration (FDA)
3rd Quarter, 2015
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. filed a lobbying registration on July 14, 2015 to represent Alpha-1 Foundation, effective July 15, 2015.
Original Filing: 300733785.xml
Issue(s) they said they’d lobby about: Labor - HHS Appropriations, NIH, FDA, CMS, 21st Century Cures .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate